Estradiol/Levonorgestrel

Tier C — Watch / trade

Bayer

Originator

2003

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：ERs, PR

Brand：Climara Pro, Fem7 Combi, Wellnara

Indications (approved)：血管疾病, Postmenopausal osteoporosis, Vasomotor symptoms

Regional status

Approved

2003-11-21

China

Japan

Factories producing this API9

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

9 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Estradiol/Levonorgestrel?

Approved indications include: 血管疾病, Postmenopausal osteoporosis, Vasomotor symptoms.

When does the Estradiol/Levonorgestrel patent expire?

No public expiry year is available for Estradiol/Levonorgestrel yet; this page updates once verified.

How do I get a quote for Estradiol/Levonorgestrel intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27